Discover our campus

Home > Our work > World Campus > Discover our campus

Frontiers of hope: Highlights from Inspire2Live World Campus sessions

Inspire2Live World Campus has hosted a series of insightful lectures and sessions featuring experts from various fields related to cancer research, treatment, and patient care. These sessions not only featured groundbreaking research and developments but also emphasized the importance of a patient-centric approach to cancer care. Experts like Nobel Laureates and leading clinicians shared their knowledge, highlighting Inspire2Live’s commitment to improving cancer care globally.

Category

Professor Wil Ngwa on Cancer Moonshot 2.0 Win-win collaboration opportunities for global cancer control

More about our Inspire2Live World Campus sessions

Inspire2Live World Campus has hosted a series of insightful lectures and sessions featuring experts from various fields related to cancer research, treatment, and patient care. Highlights include:

  • Innovative Treatments and Technologies: Sessions covered novel therapeutic agents in cancer, the use of artificial intelligence in drug design, and the potential of CAR-T cell therapy from a patient’s perspective.
  • Patient Care and Quality of Life: Experts discussed the impact of cancer on quality of life post-treatment, the importance of patient education, engagement, and empowerment, and the benefits of minimally invasive therapies.
  • Precision Oncology and Early Detection: The acceleration of precision oncology implementation in low and middle-income countries and multi-cancer early detection were key topics.
  • Global Health Initiatives: The sessions showcased efforts to address specific cancer types like esophageal cancer in Eastern Africa and the global initiative to combat HPV-related cancers.
  • Cancer and Lifestyle: The role of lifestyle factors, including fasting mimicking diets in cancer treatment and the intersection of cancer treatment with COVID-19 vaccines, were explored.
  • Open Science and Data: Talks on open source pharma, the EURETOS database, and the utilization of artificial intelligence in cervical cancer provided insights into the future of cancer research.